

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.23261508 |
| 2 | cellular ketone body metabolic process (GO:0046950) | 5.10777880 |
| 3 | proteasome assembly (GO:0043248) | 4.86991603 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 4.83659500 |
| 5 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.83659500 |
| 6 | ketone body metabolic process (GO:1902224) | 4.63868824 |
| 7 | cullin deneddylation (GO:0010388) | 4.37371269 |
| 8 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.33603697 |
| 9 | inositol phosphate catabolic process (GO:0071545) | 4.32748416 |
| 10 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.26774367 |
| 11 | negative regulation of execution phase of apoptosis (GO:1900118) | 4.22226884 |
| 12 | protein neddylation (GO:0045116) | 4.22036923 |
| 13 | protein deneddylation (GO:0000338) | 4.21911628 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 4.16305879 |
| 15 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 4.15700361 |
| 16 | inositol phosphate dephosphorylation (GO:0046855) | 4.11837299 |
| 17 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 4.11837299 |
| 18 | protein complex biogenesis (GO:0070271) | 4.10934988 |
| 19 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.10313426 |
| 20 | pteridine-containing compound biosynthetic process (GO:0042559) | 4.09977703 |
| 21 | chaperone-mediated protein transport (GO:0072321) | 4.03337508 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 4.00178816 |
| 23 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.99917969 |
| 24 | NADH dehydrogenase complex assembly (GO:0010257) | 3.99917969 |
| 25 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.99917969 |
| 26 | respiratory electron transport chain (GO:0022904) | 3.98544339 |
| 27 | DNA deamination (GO:0045006) | 3.97534963 |
| 28 | electron transport chain (GO:0022900) | 3.89071163 |
| 29 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.87866620 |
| 30 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.84799708 |
| 31 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.84511713 |
| 32 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.81788625 |
| 33 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.79214847 |
| 34 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.78991657 |
| 35 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.76848407 |
| 36 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.76848407 |
| 37 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.75236373 |
| 38 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.75236373 |
| 39 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.75236373 |
| 40 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.71853120 |
| 41 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.67794842 |
| 42 | lactate metabolic process (GO:0006089) | 3.66931964 |
| 43 | negative regulation of ligase activity (GO:0051352) | 3.66094242 |
| 44 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.66094242 |
| 45 | ribosomal small subunit assembly (GO:0000028) | 3.62182945 |
| 46 | regulation of mitochondrial translation (GO:0070129) | 3.61621204 |
| 47 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.61230075 |
| 48 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.61230075 |
| 49 | epithelial cell fate commitment (GO:0072148) | 3.55416655 |
| 50 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.55333738 |
| 51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.55293159 |
| 52 | L-phenylalanine metabolic process (GO:0006558) | 3.55293159 |
| 53 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.52052903 |
| 54 | termination of RNA polymerase III transcription (GO:0006386) | 3.51211374 |
| 55 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.51211374 |
| 56 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.47183166 |
| 57 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.47183166 |
| 58 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.46273620 |
| 59 | cytochrome complex assembly (GO:0017004) | 3.46171804 |
| 60 | 7-methylguanosine mRNA capping (GO:0006370) | 3.45242560 |
| 61 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.43551355 |
| 62 | polyol catabolic process (GO:0046174) | 3.43481025 |
| 63 | RNA capping (GO:0036260) | 3.43114568 |
| 64 | 7-methylguanosine RNA capping (GO:0009452) | 3.43114568 |
| 65 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.34619106 |
| 66 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.34473375 |
| 67 | L-phenylalanine catabolic process (GO:0006559) | 3.34473375 |
| 68 | signal peptide processing (GO:0006465) | 3.33542468 |
| 69 | regulation of hexokinase activity (GO:1903299) | 3.30370223 |
| 70 | regulation of glucokinase activity (GO:0033131) | 3.30370223 |
| 71 | respiratory chain complex IV assembly (GO:0008535) | 3.27715405 |
| 72 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.27602579 |
| 73 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.22889417 |
| 74 | oxidative phosphorylation (GO:0006119) | 3.22805412 |
| 75 | rRNA modification (GO:0000154) | 3.22766693 |
| 76 | C-terminal protein lipidation (GO:0006501) | 3.22442950 |
| 77 | insulin secretion (GO:0030073) | 3.21004826 |
| 78 | protein targeting to mitochondrion (GO:0006626) | 3.17020320 |
| 79 | positive regulation of ligase activity (GO:0051351) | 3.16241441 |
| 80 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.11092900 |
| 81 | establishment of protein localization to mitochondrion (GO:0072655) | 3.10363309 |
| 82 | peptide hormone processing (GO:0016486) | 3.09013587 |
| 83 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.08549615 |
| 84 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.08549615 |
| 85 | glucosamine-containing compound catabolic process (GO:1901072) | 3.07615265 |
| 86 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.07303419 |
| 87 | nitric oxide biosynthetic process (GO:0006809) | 3.04870419 |
| 88 | platelet dense granule organization (GO:0060155) | 3.03901017 |
| 89 | endocrine pancreas development (GO:0031018) | 3.01718063 |
| 90 | GTP biosynthetic process (GO:0006183) | 3.01646935 |
| 91 | branched-chain amino acid catabolic process (GO:0009083) | 3.01381811 |
| 92 | positive regulation of insulin secretion (GO:0032024) | 3.00693208 |
| 93 | glycerophospholipid catabolic process (GO:0046475) | 2.99797625 |
| 94 | establishment of viral latency (GO:0019043) | 2.97568065 |
| 95 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.96608711 |
| 96 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.95655373 |
| 97 | iron-sulfur cluster assembly (GO:0016226) | 2.95197526 |
| 98 | metallo-sulfur cluster assembly (GO:0031163) | 2.95197526 |
| 99 | peptidyl-histidine modification (GO:0018202) | 2.93610879 |
| 100 | positive regulation of cell cycle arrest (GO:0071158) | 2.93242138 |
| 101 | mannosylation (GO:0097502) | 2.92750322 |
| 102 | retinol metabolic process (GO:0042572) | 2.91282762 |
| 103 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.90898739 |
| 104 | protein-cofactor linkage (GO:0018065) | 2.90137205 |
| 105 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.89376213 |
| 106 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.88775289 |
| 107 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.88322873 |
| 108 | xenobiotic catabolic process (GO:0042178) | 2.87844981 |
| 109 | regulation of cellular amine metabolic process (GO:0033238) | 2.87377238 |
| 110 | establishment of integrated proviral latency (GO:0075713) | 2.87181983 |
| 111 | protein localization to mitochondrion (GO:0070585) | 2.85313331 |
| 112 | translation (GO:0006412) | 2.84876407 |
| 113 | C-terminal protein amino acid modification (GO:0018410) | 2.84710861 |
| 114 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.84499872 |
| 115 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.83009369 |
| 116 | cotranslational protein targeting to membrane (GO:0006613) | 2.81215013 |
| 117 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.80867402 |
| 118 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.78459587 |
| 119 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.78459587 |
| 120 | maturation of SSU-rRNA (GO:0030490) | 2.78435421 |
| 121 | telomere maintenance via recombination (GO:0000722) | 2.76979417 |
| 122 | spliceosomal snRNP assembly (GO:0000387) | 2.76413628 |
| 123 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.76172088 |
| 124 | auditory receptor cell differentiation (GO:0042491) | 2.75996465 |
| 125 | cell cycle G1/S phase transition (GO:0044843) | 2.75592833 |
| 126 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.75592833 |
| 127 | protein targeting to ER (GO:0045047) | 2.75558470 |
| 128 | positive regulation of gluconeogenesis (GO:0045722) | 2.73665847 |
| 129 | ribosomal small subunit biogenesis (GO:0042274) | 2.73617188 |
| 130 | de novo protein folding (GO:0006458) | 2.71883542 |
| 131 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.71395904 |
| 132 | cellular component biogenesis (GO:0044085) | 2.71365646 |
| 133 | rRNA methylation (GO:0031167) | 2.70854840 |
| 134 | regulation of execution phase of apoptosis (GO:1900117) | 2.69955572 |
| 135 | pseudouridine synthesis (GO:0001522) | 2.69259965 |
| 136 | S-adenosylmethionine metabolic process (GO:0046500) | 2.69002911 |
| 137 | regulation of ligase activity (GO:0051340) | 2.68951806 |
| 138 | axoneme assembly (GO:0035082) | 2.68095704 |
| 139 | cellular response to interferon-beta (GO:0035458) | 2.67899849 |
| 140 | de novo posttranslational protein folding (GO:0051084) | 2.66968186 |
| 141 | protein localization to endoplasmic reticulum (GO:0070972) | 2.66950136 |
| 142 | magnesium ion transport (GO:0015693) | 2.64858122 |
| 143 | keratinocyte development (GO:0003334) | 2.64267197 |
| 144 | prenylation (GO:0097354) | 2.62869687 |
| 145 | protein prenylation (GO:0018342) | 2.62869687 |
| 146 | positive regulation of calcium ion import (GO:0090280) | 2.61287349 |
| 147 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.60578103 |
| 148 | detection of calcium ion (GO:0005513) | 2.60160653 |
| 149 | protein maturation by protein folding (GO:0022417) | 2.59636357 |
| 150 | positive regulation of actin filament depolymerization (GO:0030836) | 2.58344519 |
| 151 | hydrogen ion transmembrane transport (GO:1902600) | 2.57005164 |
| 152 | positive regulation of peptide hormone secretion (GO:0090277) | 2.56260274 |
| 153 | aromatic amino acid family catabolic process (GO:0009074) | 2.54193697 |
| 154 | regulation of cilium movement (GO:0003352) | 2.53271105 |
| 155 | zinc ion transport (GO:0006829) | 2.49315164 |
| 156 | proton transport (GO:0015992) | 2.49240986 |
| 157 | phenylpropanoid metabolic process (GO:0009698) | 2.48552537 |
| 158 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.48493896 |
| 159 | hydrogen transport (GO:0006818) | 2.46210294 |
| 160 | glandular epithelial cell differentiation (GO:0002067) | 2.44449897 |
| 161 | L-methionine salvage (GO:0071267) | 2.43971227 |
| 162 | L-methionine biosynthetic process (GO:0071265) | 2.43971227 |
| 163 | amino acid salvage (GO:0043102) | 2.43971227 |
| 164 | positive regulation of peptide secretion (GO:0002793) | 2.43453311 |
| 165 | GPI anchor biosynthetic process (GO:0006506) | 2.42639492 |
| 166 | nodal signaling pathway (GO:0038092) | 2.42436167 |
| 167 | glutathione derivative biosynthetic process (GO:1901687) | 2.42360202 |
| 168 | glutathione derivative metabolic process (GO:1901685) | 2.42360202 |
| 169 | zinc ion transmembrane transport (GO:0071577) | 2.41481071 |
| 170 | aldehyde catabolic process (GO:0046185) | 2.40390796 |
| 171 | protein autoprocessing (GO:0016540) | 2.40238635 |
| 172 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.39227753 |
| 173 | regulation of oxidative phosphorylation (GO:0002082) | 2.39065482 |
| 174 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.38118504 |
| 175 | GPI anchor metabolic process (GO:0006505) | 2.36109276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 7.36370635 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.05181649 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.44344294 |
| 4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.03101936 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.02497726 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.84780222 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.65299576 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.47936551 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.25023738 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.21489036 |
| 11 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.08311372 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.05432228 |
| 13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.99723720 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.99018596 |
| 15 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.80684324 |
| 16 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.75820901 |
| 17 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.60061755 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.59192815 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.57860052 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.57687622 |
| 21 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.54484249 |
| 22 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.51163259 |
| 23 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.35546555 |
| 24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.26600646 |
| 25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.25713420 |
| 26 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.23082850 |
| 27 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.17105347 |
| 28 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.16174975 |
| 29 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.15328349 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.15293660 |
| 31 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.14177593 |
| 32 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.12656766 |
| 33 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.07216973 |
| 34 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.98270150 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.96290408 |
| 36 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.95843550 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.92849641 |
| 38 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.90241246 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89655547 |
| 40 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.89227461 |
| 41 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86728271 |
| 42 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.86650719 |
| 43 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.85348107 |
| 44 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.81733867 |
| 45 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.79060054 |
| 46 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.76899501 |
| 47 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.73835819 |
| 48 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.70057588 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.69297138 |
| 50 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.66693610 |
| 51 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.65622623 |
| 52 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.62896952 |
| 53 | P300_19829295_ChIP-Seq_ESCs_Human | 1.50960332 |
| 54 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.49630917 |
| 55 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.46137648 |
| 56 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.46042727 |
| 57 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45407149 |
| 58 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.40773657 |
| 59 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.40668625 |
| 60 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.39551631 |
| 61 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.39277311 |
| 62 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.39277311 |
| 63 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38784249 |
| 64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37982448 |
| 65 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37139965 |
| 66 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.36832194 |
| 67 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.35477587 |
| 68 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.33881450 |
| 69 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.32947574 |
| 70 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.32914899 |
| 71 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.31558584 |
| 72 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.30817381 |
| 73 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.29254312 |
| 74 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.29170295 |
| 75 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.27064683 |
| 76 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.26616458 |
| 77 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24899895 |
| 78 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.24566575 |
| 79 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.24504826 |
| 80 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.23447583 |
| 81 | AR_20517297_ChIP-Seq_VCAP_Human | 1.22102113 |
| 82 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.21074142 |
| 83 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20938898 |
| 84 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20392772 |
| 85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20212954 |
| 86 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.19978281 |
| 87 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.19669408 |
| 88 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.19669408 |
| 89 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.19032268 |
| 90 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.18452293 |
| 91 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.18123916 |
| 92 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18052547 |
| 93 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.17901092 |
| 94 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.16716679 |
| 95 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15902578 |
| 96 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.15315973 |
| 97 | VDR_22108803_ChIP-Seq_LS180_Human | 1.13805548 |
| 98 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.13781603 |
| 99 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.13497583 |
| 100 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.11764024 |
| 101 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.11449289 |
| 102 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.11401434 |
| 103 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11270271 |
| 104 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10802679 |
| 105 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.10358029 |
| 106 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.09062224 |
| 107 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08827680 |
| 108 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07623605 |
| 109 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.07373127 |
| 110 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.07014540 |
| 111 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.06947484 |
| 112 | FUS_26573619_Chip-Seq_HEK293_Human | 1.06891897 |
| 113 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.06835128 |
| 114 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06177286 |
| 115 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05986079 |
| 116 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05498254 |
| 117 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.04818491 |
| 118 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.03218932 |
| 119 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03016682 |
| 120 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.02190524 |
| 121 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02190418 |
| 122 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01671477 |
| 123 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.00510134 |
| 124 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.00409228 |
| 125 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00240555 |
| 126 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99924774 |
| 127 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.99916185 |
| 128 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99916185 |
| 129 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.99913796 |
| 130 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.99620969 |
| 131 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.99543775 |
| 132 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99292719 |
| 133 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98896279 |
| 134 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.97869198 |
| 135 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97617614 |
| 136 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.97165561 |
| 137 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.96944365 |
| 138 | NCOR_22424771_ChIP-Seq_293T_Human | 0.96608899 |
| 139 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.95531441 |
| 140 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.95209260 |
| 141 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.95029881 |
| 142 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.94657292 |
| 143 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93945888 |
| 144 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.93479291 |
| 145 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.93246870 |
| 146 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93131923 |
| 147 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.88879507 |
| 148 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.88026596 |
| 149 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.88010874 |
| 150 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87376474 |
| 151 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87232236 |
| 152 | EWS_26573619_Chip-Seq_HEK293_Human | 0.85274406 |
| 153 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.84203556 |
| 154 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82138297 |
| 155 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.80650116 |
| 156 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.77008138 |
| 157 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.72554534 |
| 158 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.68902427 |
| 159 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.65988844 |
| 160 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.64247040 |
| 161 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.63077542 |
| 162 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.62824552 |
| 163 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.62630229 |
| 164 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.62260318 |
| 165 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.61762647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009780_abnormal_chondrocyte_physiolo | 3.95795688 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 3.35353218 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.08278760 |
| 4 | MP0002909_abnormal_adrenal_gland | 3.05884882 |
| 5 | MP0003195_calcinosis | 2.81208008 |
| 6 | MP0006072_abnormal_retinal_apoptosis | 2.74458834 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.58217565 |
| 8 | MP0003693_abnormal_embryo_hatching | 2.55193988 |
| 9 | MP0009785_altered_susceptibility_to | 2.43677662 |
| 10 | MP0005084_abnormal_gallbladder_morpholo | 2.43103933 |
| 11 | MP0001944_abnormal_pancreas_morphology | 2.35836410 |
| 12 | MP0003880_abnormal_central_pattern | 2.31948211 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.31775485 |
| 14 | MP0000013_abnormal_adipose_tissue | 2.26835158 |
| 15 | MP0001986_abnormal_taste_sensitivity | 2.25878061 |
| 16 | MP0001188_hyperpigmentation | 2.20885194 |
| 17 | MP0008058_abnormal_DNA_repair | 2.19561221 |
| 18 | MP0001529_abnormal_vocalization | 2.13896439 |
| 19 | MP0004957_abnormal_blastocyst_morpholog | 2.12789022 |
| 20 | MP0005671_abnormal_response_to | 2.11904694 |
| 21 | MP0010386_abnormal_urinary_bladder | 2.07370505 |
| 22 | MP0008057_abnormal_DNA_replication | 2.03743106 |
| 23 | MP0000372_irregular_coat_pigmentation | 2.02035195 |
| 24 | MP0009379_abnormal_foot_pigmentation | 2.01878054 |
| 25 | MP0002876_abnormal_thyroid_physiology | 2.00309538 |
| 26 | MP0005332_abnormal_amino_acid | 1.98031150 |
| 27 | MP0010094_abnormal_chromosome_stability | 1.93370839 |
| 28 | MP0003724_increased_susceptibility_to | 1.90245432 |
| 29 | MP0002638_abnormal_pupillary_reflex | 1.88794293 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.86743719 |
| 31 | MP0003787_abnormal_imprinting | 1.86108065 |
| 32 | MP0002163_abnormal_gland_morphology | 1.83498005 |
| 33 | MP0004019_abnormal_vitamin_homeostasis | 1.83489446 |
| 34 | MP0002254_reproductive_system_inflammat | 1.82218990 |
| 35 | MP0001905_abnormal_dopamine_level | 1.81821977 |
| 36 | MP0006036_abnormal_mitochondrial_physio | 1.81200159 |
| 37 | MP0003011_delayed_dark_adaptation | 1.80757732 |
| 38 | MP0005171_absent_coat_pigmentation | 1.78217598 |
| 39 | MP0009697_abnormal_copulation | 1.71677468 |
| 40 | MP0005379_endocrine/exocrine_gland_phen | 1.71117454 |
| 41 | MP0001984_abnormal_olfaction | 1.69445422 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.64521612 |
| 43 | MP0008877_abnormal_DNA_methylation | 1.63589052 |
| 44 | MP0008007_abnormal_cellular_replicative | 1.60633140 |
| 45 | MP0001756_abnormal_urination | 1.60149069 |
| 46 | MP0006292_abnormal_olfactory_placode | 1.59476846 |
| 47 | MP0005000_abnormal_immune_tolerance | 1.58165553 |
| 48 | MP0008932_abnormal_embryonic_tissue | 1.56683053 |
| 49 | MP0005365_abnormal_bile_salt | 1.56500829 |
| 50 | MP0002736_abnormal_nociception_after | 1.55759514 |
| 51 | MP0003186_abnormal_redox_activity | 1.53771353 |
| 52 | MP0000015_abnormal_ear_pigmentation | 1.53552027 |
| 53 | MP0005551_abnormal_eye_electrophysiolog | 1.52368323 |
| 54 | MP0003077_abnormal_cell_cycle | 1.49486673 |
| 55 | MP0005253_abnormal_eye_physiology | 1.47169224 |
| 56 | MP0010329_abnormal_lipoprotein_level | 1.46830980 |
| 57 | MP0005636_abnormal_mineral_homeostasis | 1.46433296 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 1.45861314 |
| 59 | MP0003786_premature_aging | 1.44178693 |
| 60 | MP0002078_abnormal_glucose_homeostasis | 1.39368696 |
| 61 | MP0000427_abnormal_hair_cycle | 1.38483134 |
| 62 | MP0006035_abnormal_mitochondrial_morpho | 1.38084553 |
| 63 | MP0008875_abnormal_xenobiotic_pharmacok | 1.35004196 |
| 64 | MP0003646_muscle_fatigue | 1.34613353 |
| 65 | MP0005025_abnormal_response_to | 1.34594394 |
| 66 | MP0006082_CNS_inflammation | 1.32043301 |
| 67 | MP0006276_abnormal_autonomic_nervous | 1.31867730 |
| 68 | MP0001542_abnormal_bone_strength | 1.31652672 |
| 69 | MP0002090_abnormal_vision | 1.28565859 |
| 70 | MP0003718_maternal_effect | 1.27466233 |
| 71 | MP0004270_analgesia | 1.24801637 |
| 72 | MP0000681_abnormal_thyroid_gland | 1.21821649 |
| 73 | MP0002723_abnormal_immune_serum | 1.21782891 |
| 74 | MP0001853_heart_inflammation | 1.21529477 |
| 75 | MP0010678_abnormal_skin_adnexa | 1.18060564 |
| 76 | MP0002419_abnormal_innate_immunity | 1.17420754 |
| 77 | MP0001661_extended_life_span | 1.16833351 |
| 78 | MP0002160_abnormal_reproductive_system | 1.16160262 |
| 79 | MP0005408_hypopigmentation | 1.16138583 |
| 80 | MP0002420_abnormal_adaptive_immunity | 1.16033982 |
| 81 | MP0001819_abnormal_immune_cell | 1.16032251 |
| 82 | MP0003111_abnormal_nucleus_morphology | 1.15827444 |
| 83 | MP0000516_abnormal_urinary_system | 1.15475047 |
| 84 | MP0005367_renal/urinary_system_phenotyp | 1.15475047 |
| 85 | MP0002735_abnormal_chemical_nociception | 1.15355475 |
| 86 | MP0002452_abnormal_antigen_presenting | 1.15290565 |
| 87 | MP0001501_abnormal_sleep_pattern | 1.12001430 |
| 88 | MP0001968_abnormal_touch/_nociception | 1.08907178 |
| 89 | MP0000639_abnormal_adrenal_gland | 1.08678181 |
| 90 | MP0003122_maternal_imprinting | 1.07987774 |
| 91 | MP0004133_heterotaxia | 1.07188802 |
| 92 | MP0009046_muscle_twitch | 1.07002310 |
| 93 | MP0002095_abnormal_skin_pigmentation | 1.06632181 |
| 94 | MP0000631_abnormal_neuroendocrine_gland | 1.06362275 |
| 95 | MP0004142_abnormal_muscle_tone | 1.06229027 |
| 96 | MP0003763_abnormal_thymus_physiology | 1.04934172 |
| 97 | MP0003123_paternal_imprinting | 1.04390930 |
| 98 | MP0002277_abnormal_respiratory_mucosa | 1.03319551 |
| 99 | MP0003136_yellow_coat_color | 1.02853841 |
| 100 | MP0001800_abnormal_humoral_immune | 1.02486884 |
| 101 | MP0005248_abnormal_Harderian_gland | 1.01259041 |
| 102 | MP0002693_abnormal_pancreas_physiology | 0.98628482 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.98271749 |
| 104 | MP0003953_abnormal_hormone_level | 0.97810855 |
| 105 | MP0005646_abnormal_pituitary_gland | 0.97310669 |
| 106 | MP0005389_reproductive_system_phenotype | 0.95928534 |
| 107 | MP0001764_abnormal_homeostasis | 0.95797908 |
| 108 | MP0002928_abnormal_bile_duct | 0.95228964 |
| 109 | MP0003436_decreased_susceptibility_to | 0.94912708 |
| 110 | MP0005085_abnormal_gallbladder_physiolo | 0.94420799 |
| 111 | MP0002398_abnormal_bone_marrow | 0.94168272 |
| 112 | MP0008872_abnormal_physiological_respon | 0.92501084 |
| 113 | MP0008260_abnormal_autophagy | 0.92391503 |
| 114 | MP0004782_abnormal_surfactant_physiolog | 0.89831830 |
| 115 | MP0000749_muscle_degeneration | 0.89579637 |
| 116 | MP0002396_abnormal_hematopoietic_system | 0.89272039 |
| 117 | MP0005174_abnormal_tail_pigmentation | 0.88991968 |
| 118 | MP0005448_abnormal_energy_balance | 0.88619571 |
| 119 | MP0003121_genomic_imprinting | 0.87206427 |
| 120 | MP0000343_altered_response_to | 0.86674940 |
| 121 | MP0006054_spinal_hemorrhage | 0.86250372 |
| 122 | MP0005645_abnormal_hypothalamus_physiol | 0.86166747 |
| 123 | MP0004215_abnormal_myocardial_fiber | 0.84902488 |
| 124 | MP0005075_abnormal_melanosome_morpholog | 0.83927642 |
| 125 | MP0000685_abnormal_immune_system | 0.83841315 |
| 126 | MP0000716_abnormal_immune_system | 0.83046164 |
| 127 | MP0002837_dystrophic_cardiac_calcinosis | 0.82830327 |
| 128 | MP0009745_abnormal_behavioral_response | 0.81908409 |
| 129 | MP0003879_abnormal_hair_cell | 0.81712832 |
| 130 | MP0005535_abnormal_body_temperature | 0.81280826 |
| 131 | MP0004147_increased_porphyrin_level | 0.81154547 |
| 132 | MP0002064_seizures | 0.81085517 |
| 133 | MP0002734_abnormal_mechanical_nocicepti | 0.80807562 |
| 134 | MP0000358_abnormal_cell_content/ | 0.80423901 |
| 135 | MP0000858_altered_metastatic_potential | 0.80110092 |
| 136 | MP0005387_immune_system_phenotype | 0.79506286 |
| 137 | MP0001790_abnormal_immune_system | 0.79506286 |
| 138 | MP0002272_abnormal_nervous_system | 0.79372197 |
| 139 | MP0003183_abnormal_peptide_metabolism | 0.78851541 |
| 140 | MP0002332_abnormal_exercise_endurance | 0.78028203 |
| 141 | MP0000490_abnormal_crypts_of | 0.77798058 |
| 142 | MP0000689_abnormal_spleen_morphology | 0.77725766 |
| 143 | MP0005310_abnormal_salivary_gland | 0.77518374 |
| 144 | MP0004885_abnormal_endolymph | 0.77031832 |
| 145 | MP0002429_abnormal_blood_cell | 0.76354856 |
| 146 | MP0000538_abnormal_urinary_bladder | 0.76250534 |
| 147 | MP0003252_abnormal_bile_duct | 0.75302652 |
| 148 | MP0004043_abnormal_pH_regulation | 0.74759079 |
| 149 | MP0009643_abnormal_urine_homeostasis | 0.74606090 |
| 150 | MP0003172_abnormal_lysosome_physiology | 0.74121579 |
| 151 | MP0005410_abnormal_fertilization | 0.73941519 |
| 152 | MP0002938_white_spotting | 0.73777517 |
| 153 | MP0002118_abnormal_lipid_homeostasis | 0.73654401 |
| 154 | MP0002166_altered_tumor_susceptibility | 0.72197451 |
| 155 | MP0000003_abnormal_adipose_tissue | 0.71364043 |
| 156 | MP0008004_abnormal_stomach_pH | 0.71071333 |
| 157 | MP0002229_neurodegeneration | 0.70426405 |
| 158 | MP0002557_abnormal_social/conspecific_i | 0.70090015 |
| 159 | MP0005386_behavior/neurological_phenoty | 0.67959563 |
| 160 | MP0004924_abnormal_behavior | 0.67959563 |
| 161 | MP0001970_abnormal_pain_threshold | 0.67368413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 6.07228639 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.61804316 |
| 3 | Mitochondrial inheritance (HP:0001427) | 5.32512573 |
| 4 | Progressive macrocephaly (HP:0004481) | 5.01196347 |
| 5 | Increased CSF lactate (HP:0002490) | 4.70121363 |
| 6 | Hepatocellular necrosis (HP:0001404) | 4.51624383 |
| 7 | Acute encephalopathy (HP:0006846) | 4.49873154 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.36156502 |
| 9 | Hepatic necrosis (HP:0002605) | 3.87086133 |
| 10 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.74395775 |
| 11 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.74395775 |
| 12 | Increased hepatocellular lipid droplets (HP:0006565) | 3.66415478 |
| 13 | Exercise intolerance (HP:0003546) | 3.43817720 |
| 14 | 3-Methylglutaconic aciduria (HP:0003535) | 3.35260436 |
| 15 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.35150182 |
| 16 | Hypoglycemic coma (HP:0001325) | 3.34025929 |
| 17 | Increased serum lactate (HP:0002151) | 3.33210355 |
| 18 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.28980431 |
| 19 | Ketoacidosis (HP:0001993) | 3.26081457 |
| 20 | Abnormality of vitamin B metabolism (HP:0004340) | 3.22235250 |
| 21 | Increased serum pyruvate (HP:0003542) | 3.21149639 |
| 22 | Abnormality of glycolysis (HP:0004366) | 3.21149639 |
| 23 | Hyperglycemia (HP:0003074) | 3.16405724 |
| 24 | Type I transferrin isoform profile (HP:0003642) | 3.15917031 |
| 25 | Birth length less than 3rd percentile (HP:0003561) | 3.12040704 |
| 26 | Double outlet right ventricle (HP:0001719) | 3.11873500 |
| 27 | Congenital malformation of the right heart (HP:0011723) | 3.11873500 |
| 28 | Lipid accumulation in hepatocytes (HP:0006561) | 3.10393907 |
| 29 | Lactic acidosis (HP:0003128) | 3.07683785 |
| 30 | Methylmalonic acidemia (HP:0002912) | 3.07012992 |
| 31 | Optic disc pallor (HP:0000543) | 3.06348630 |
| 32 | Respiratory failure (HP:0002878) | 3.05954669 |
| 33 | Large for gestational age (HP:0001520) | 2.99104988 |
| 34 | Exertional dyspnea (HP:0002875) | 2.96449115 |
| 35 | Hypothermia (HP:0002045) | 2.96111771 |
| 36 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.94662673 |
| 37 | Intestinal atresia (HP:0011100) | 2.81301509 |
| 38 | Renal Fanconi syndrome (HP:0001994) | 2.78572347 |
| 39 | Conjunctival hamartoma (HP:0100780) | 2.78205105 |
| 40 | Hypoglycemic seizures (HP:0002173) | 2.73935830 |
| 41 | Glycosuria (HP:0003076) | 2.73025659 |
| 42 | Abnormality of urine glucose concentration (HP:0011016) | 2.73025659 |
| 43 | Increased intramyocellular lipid droplets (HP:0012240) | 2.69596695 |
| 44 | Abnormality of vitamin metabolism (HP:0100508) | 2.66333917 |
| 45 | Abnormal number of erythroid precursors (HP:0012131) | 2.64573633 |
| 46 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.59392897 |
| 47 | Cerebral edema (HP:0002181) | 2.59307988 |
| 48 | Methylmalonic aciduria (HP:0012120) | 2.55683511 |
| 49 | Abnormal hair whorl (HP:0010721) | 2.54537617 |
| 50 | Leukodystrophy (HP:0002415) | 2.51815216 |
| 51 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.46441278 |
| 52 | Abnormality of alanine metabolism (HP:0010916) | 2.46441278 |
| 53 | Hyperalaninemia (HP:0003348) | 2.46441278 |
| 54 | Ketosis (HP:0001946) | 2.44387226 |
| 55 | Aplastic anemia (HP:0001915) | 2.44279512 |
| 56 | Medial flaring of the eyebrow (HP:0010747) | 2.42912512 |
| 57 | Tongue fasciculations (HP:0001308) | 2.42092228 |
| 58 | Poor head control (HP:0002421) | 2.41229401 |
| 59 | Increased CSF protein (HP:0002922) | 2.41151395 |
| 60 | Hemiparesis (HP:0001269) | 2.39060230 |
| 61 | Microvesicular hepatic steatosis (HP:0001414) | 2.38656227 |
| 62 | Respiratory difficulties (HP:0002880) | 2.38478523 |
| 63 | Abnormality of midbrain morphology (HP:0002418) | 2.36405859 |
| 64 | Molar tooth sign on MRI (HP:0002419) | 2.36405859 |
| 65 | Nephrogenic diabetes insipidus (HP:0009806) | 2.34724699 |
| 66 | Reticulocytopenia (HP:0001896) | 2.30479485 |
| 67 | Abnormal protein glycosylation (HP:0012346) | 2.30264348 |
| 68 | Abnormal glycosylation (HP:0012345) | 2.30264348 |
| 69 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.30264348 |
| 70 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.30264348 |
| 71 | True hermaphroditism (HP:0010459) | 2.28257539 |
| 72 | Neuroendocrine neoplasm (HP:0100634) | 2.27679789 |
| 73 | Neoplasm of the adrenal gland (HP:0100631) | 2.26750365 |
| 74 | Lethargy (HP:0001254) | 2.26480638 |
| 75 | Congenital primary aphakia (HP:0007707) | 2.25767263 |
| 76 | Vascular calcification (HP:0004934) | 2.22468020 |
| 77 | Hypokinesia (HP:0002375) | 2.22120217 |
| 78 | Abnormality of the renal cortex (HP:0011035) | 2.21109092 |
| 79 | Furrowed tongue (HP:0000221) | 2.20090162 |
| 80 | Pancreatic fibrosis (HP:0100732) | 2.19698351 |
| 81 | Premature graying of hair (HP:0002216) | 2.19596707 |
| 82 | Rough bone trabeculation (HP:0100670) | 2.19062742 |
| 83 | Type 2 muscle fiber atrophy (HP:0003554) | 2.18788371 |
| 84 | Nephronophthisis (HP:0000090) | 2.18112324 |
| 85 | Hamartoma of the eye (HP:0010568) | 2.17642181 |
| 86 | Agnosia (HP:0010524) | 2.16304714 |
| 87 | Gait imbalance (HP:0002141) | 2.14575101 |
| 88 | Increased IgM level (HP:0003496) | 2.13697710 |
| 89 | Muscular hypotonia of the trunk (HP:0008936) | 2.13361706 |
| 90 | Cerebral hypomyelination (HP:0006808) | 2.12710173 |
| 91 | Palpitations (HP:0001962) | 2.12438245 |
| 92 | Congenital sensorineural hearing impairment (HP:0008527) | 2.12162325 |
| 93 | Generalized aminoaciduria (HP:0002909) | 2.10948894 |
| 94 | Recurrent abscess formation (HP:0002722) | 2.09328971 |
| 95 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.08156370 |
| 96 | Increased muscle lipid content (HP:0009058) | 2.07447550 |
| 97 | Renal cortical cysts (HP:0000803) | 2.05570995 |
| 98 | Hypoalbuminemia (HP:0003073) | 2.03333183 |
| 99 | Abnormal albumin level (HP:0012116) | 2.03333183 |
| 100 | Symptomatic seizures (HP:0011145) | 2.02724079 |
| 101 | Enlarged penis (HP:0000040) | 2.02665840 |
| 102 | Unsteady gait (HP:0002317) | 2.02353242 |
| 103 | Pancreatic cysts (HP:0001737) | 2.00143233 |
| 104 | Orthostatic hypotension (HP:0001278) | 1.98224784 |
| 105 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.97389153 |
| 106 | Pallor (HP:0000980) | 1.97380831 |
| 107 | Abnormality of the anterior horn cell (HP:0006802) | 1.97340079 |
| 108 | Degeneration of anterior horn cells (HP:0002398) | 1.97340079 |
| 109 | Abnormality of renal resorption (HP:0011038) | 1.96798119 |
| 110 | Progressive neurologic deterioration (HP:0002344) | 1.96217921 |
| 111 | Congenital stationary night blindness (HP:0007642) | 1.94033194 |
| 112 | Postural tremor (HP:0002174) | 1.93427228 |
| 113 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.92773310 |
| 114 | Late onset (HP:0003584) | 1.91341849 |
| 115 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.90872089 |
| 116 | Reduced antithrombin III activity (HP:0001976) | 1.88809668 |
| 117 | CNS demyelination (HP:0007305) | 1.88397201 |
| 118 | Muscle fiber atrophy (HP:0100295) | 1.88096420 |
| 119 | Urethral obstruction (HP:0000796) | 1.88031760 |
| 120 | Muscle fibrillation (HP:0010546) | 1.86968093 |
| 121 | Oral leukoplakia (HP:0002745) | 1.86789531 |
| 122 | Proximal tubulopathy (HP:0000114) | 1.84586129 |
| 123 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.84191525 |
| 124 | Cardiovascular calcification (HP:0011915) | 1.84078440 |
| 125 | Tubular atrophy (HP:0000092) | 1.83862966 |
| 126 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.82486682 |
| 127 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.82486682 |
| 128 | Testicular atrophy (HP:0000029) | 1.80990036 |
| 129 | Emotional lability (HP:0000712) | 1.80283216 |
| 130 | Hyperphosphaturia (HP:0003109) | 1.79921682 |
| 131 | Pheochromocytoma (HP:0002666) | 1.79834867 |
| 132 | X-linked dominant inheritance (HP:0001423) | 1.77362796 |
| 133 | Irregular epiphyses (HP:0010582) | 1.77036661 |
| 134 | Patent foramen ovale (HP:0001655) | 1.75472680 |
| 135 | Focal motor seizures (HP:0011153) | 1.72875238 |
| 136 | Breast hypoplasia (HP:0003187) | 1.71253633 |
| 137 | Abnormal trabecular bone morphology (HP:0100671) | 1.70833731 |
| 138 | Atonic seizures (HP:0010819) | 1.70073714 |
| 139 | Thrombocytosis (HP:0001894) | 1.68951712 |
| 140 | Pancytopenia (HP:0001876) | 1.68305668 |
| 141 | IgM deficiency (HP:0002850) | 1.67752424 |
| 142 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.67596508 |
| 143 | Macrocytic anemia (HP:0001972) | 1.66301115 |
| 144 | Abnormality of the preputium (HP:0100587) | 1.66273407 |
| 145 | IgG deficiency (HP:0004315) | 1.65173619 |
| 146 | Abnormal pupillary function (HP:0007686) | 1.65057693 |
| 147 | 11 pairs of ribs (HP:0000878) | 1.62569491 |
| 148 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.61994062 |
| 149 | Hypoplasia of the fovea (HP:0007750) | 1.61994062 |
| 150 | Cleft eyelid (HP:0000625) | 1.61947481 |
| 151 | Poor suck (HP:0002033) | 1.60221555 |
| 152 | Poor coordination (HP:0002370) | 1.60209450 |
| 153 | Gliosis (HP:0002171) | 1.58683030 |
| 154 | Vacuolated lymphocytes (HP:0001922) | 1.58549003 |
| 155 | Postnatal microcephaly (HP:0005484) | 1.58532138 |
| 156 | Recurrent bacterial skin infections (HP:0005406) | 1.57244826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.02392328 |
| 2 | STK16 | 4.03578651 |
| 3 | MAP3K12 | 3.30250379 |
| 4 | EIF2AK1 | 3.22635541 |
| 5 | WNK3 | 3.08771898 |
| 6 | MAP4K2 | 2.91183962 |
| 7 | NME1 | 2.69862991 |
| 8 | CASK | 2.63736669 |
| 9 | EIF2AK3 | 2.49619853 |
| 10 | BUB1 | 2.47713400 |
| 11 | PHKG1 | 2.39988564 |
| 12 | PHKG2 | 2.39988564 |
| 13 | NME2 | 2.36612889 |
| 14 | TSSK6 | 2.35256799 |
| 15 | PBK | 2.28012467 |
| 16 | FGFR2 | 2.25838357 |
| 17 | VRK1 | 2.20775297 |
| 18 | SRPK1 | 2.16086131 |
| 19 | PIM2 | 2.07904118 |
| 20 | GRK1 | 2.07210102 |
| 21 | WEE1 | 1.93433291 |
| 22 | MST4 | 1.89739090 |
| 23 | MAP2K7 | 1.88314288 |
| 24 | TRIM28 | 1.84672798 |
| 25 | CCNB1 | 1.64558369 |
| 26 | CDK8 | 1.62439707 |
| 27 | VRK2 | 1.61841372 |
| 28 | ZAK | 1.61593982 |
| 29 | IRAK3 | 1.57299350 |
| 30 | FER | 1.54531746 |
| 31 | TXK | 1.51478797 |
| 32 | MYLK | 1.50898220 |
| 33 | IRAK4 | 1.48698665 |
| 34 | MAP2K6 | 1.48484464 |
| 35 | NUAK1 | 1.48149225 |
| 36 | PLK4 | 1.44559595 |
| 37 | MKNK2 | 1.42572019 |
| 38 | BMPR2 | 1.42053886 |
| 39 | MAP3K14 | 1.39331676 |
| 40 | ARAF | 1.36986499 |
| 41 | CDK19 | 1.35332345 |
| 42 | BMPR1B | 1.33680160 |
| 43 | CSNK1G1 | 1.29039357 |
| 44 | PAK3 | 1.29004055 |
| 45 | STK3 | 1.28057627 |
| 46 | INSRR | 1.26738848 |
| 47 | MKNK1 | 1.24197259 |
| 48 | PLK2 | 1.22659472 |
| 49 | TNIK | 1.22307852 |
| 50 | EIF2AK2 | 1.21740109 |
| 51 | ADRBK2 | 1.20951356 |
| 52 | TLK1 | 1.18770261 |
| 53 | CSNK1G3 | 1.17415479 |
| 54 | PINK1 | 1.15008785 |
| 55 | YES1 | 1.13304757 |
| 56 | TRPM7 | 1.13124180 |
| 57 | SIK3 | 1.13033838 |
| 58 | TEC | 1.11270894 |
| 59 | DAPK2 | 1.10338006 |
| 60 | AKT3 | 1.09740327 |
| 61 | TESK1 | 1.09057795 |
| 62 | BLK | 1.08702515 |
| 63 | MAPKAPK3 | 1.08192973 |
| 64 | PASK | 1.07413206 |
| 65 | BRSK2 | 1.06507667 |
| 66 | LIMK1 | 1.03676763 |
| 67 | ACVR1B | 1.03537594 |
| 68 | CSNK1G2 | 1.00417930 |
| 69 | TESK2 | 1.00144313 |
| 70 | STK39 | 0.97949588 |
| 71 | GRK7 | 0.97241860 |
| 72 | DAPK1 | 0.96904654 |
| 73 | BRAF | 0.95109058 |
| 74 | BCR | 0.94731471 |
| 75 | ERBB3 | 0.94187484 |
| 76 | PLK3 | 0.92327052 |
| 77 | CAMKK2 | 0.92130755 |
| 78 | PRKCI | 0.90376273 |
| 79 | KIT | 0.87754672 |
| 80 | WNK4 | 0.87232663 |
| 81 | CAMK2D | 0.85387012 |
| 82 | STK38L | 0.84871739 |
| 83 | STK4 | 0.84760790 |
| 84 | KDR | 0.82201476 |
| 85 | IKBKE | 0.80539693 |
| 86 | NTRK3 | 0.80410950 |
| 87 | RIPK4 | 0.79224067 |
| 88 | MUSK | 0.78999142 |
| 89 | FGFR3 | 0.77285513 |
| 90 | BCKDK | 0.75753233 |
| 91 | TBK1 | 0.72481076 |
| 92 | CSNK1A1L | 0.70923886 |
| 93 | OBSCN | 0.70277401 |
| 94 | CDC7 | 0.68230961 |
| 95 | IKBKB | 0.67837178 |
| 96 | STK24 | 0.64721455 |
| 97 | NLK | 0.61568735 |
| 98 | NEK6 | 0.61060969 |
| 99 | PDK2 | 0.60250326 |
| 100 | BRSK1 | 0.59105959 |
| 101 | CSNK2A1 | 0.59032390 |
| 102 | PLK1 | 0.58979253 |
| 103 | LYN | 0.58001136 |
| 104 | MAP3K11 | 0.56275046 |
| 105 | SYK | 0.54997047 |
| 106 | PTK2B | 0.54939873 |
| 107 | AURKA | 0.53731717 |
| 108 | TYK2 | 0.53487139 |
| 109 | FES | 0.52794590 |
| 110 | MAP3K2 | 0.52752947 |
| 111 | GRK5 | 0.52046335 |
| 112 | PRKD3 | 0.51236977 |
| 113 | PNCK | 0.50634791 |
| 114 | NEK1 | 0.49790946 |
| 115 | MAPK13 | 0.48901307 |
| 116 | ABL2 | 0.48828817 |
| 117 | JAK3 | 0.48804041 |
| 118 | ATR | 0.47605845 |
| 119 | NEK9 | 0.46651853 |
| 120 | PAK4 | 0.44238711 |
| 121 | CSNK1A1 | 0.44055663 |
| 122 | TNK2 | 0.43857926 |
| 123 | AURKB | 0.43038451 |
| 124 | IRAK1 | 0.41455433 |
| 125 | RPS6KA4 | 0.41041477 |
| 126 | CSNK2A2 | 0.40937275 |
| 127 | CAMK2A | 0.40250689 |
| 128 | TAF1 | 0.39885000 |
| 129 | RPS6KA5 | 0.39370916 |
| 130 | MAP3K4 | 0.37788664 |
| 131 | DYRK2 | 0.37656689 |
| 132 | FLT3 | 0.37397529 |
| 133 | LCK | 0.35415299 |
| 134 | PRKCE | 0.34587842 |
| 135 | TGFBR1 | 0.34448239 |
| 136 | ILK | 0.33722779 |
| 137 | BTK | 0.33437037 |
| 138 | MAP3K5 | 0.33283938 |
| 139 | DAPK3 | 0.32642056 |
| 140 | PRKCD | 0.32146250 |
| 141 | ADRBK1 | 0.31347057 |
| 142 | MAPKAPK5 | 0.30396970 |
| 143 | AKT2 | 0.30112985 |
| 144 | PRKCG | 0.30102385 |
| 145 | OXSR1 | 0.29854447 |
| 146 | GSK3A | 0.29368491 |
| 147 | PRKG1 | 0.28783322 |
| 148 | PRKACA | 0.28471576 |
| 149 | CAMK2G | 0.26809559 |
| 150 | MAP3K9 | 0.25839853 |
| 151 | PRKACB | 0.25016836 |
| 152 | ATM | 0.24440439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.67351578 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.97645569 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.65060742 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.26143337 |
| 5 | Protein export_Homo sapiens_hsa03060 | 3.25681059 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 3.19235944 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.16872991 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.87070651 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 2.59189125 |
| 10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.48199726 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.37219560 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.34659098 |
| 13 | Mismatch repair_Homo sapiens_hsa03430 | 2.25648463 |
| 14 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.19047178 |
| 15 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.18741967 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.13860173 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.13103788 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.12609918 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.06214542 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.96830087 |
| 21 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.96331744 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.90680681 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.76574215 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.74591663 |
| 25 | Spliceosome_Homo sapiens_hsa03040 | 1.70010542 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.64658059 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.61885626 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.60718990 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.52750890 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.51095140 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49843656 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.48062445 |
| 33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.42816061 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.41063963 |
| 35 | Base excision repair_Homo sapiens_hsa03410 | 1.39652308 |
| 36 | RNA degradation_Homo sapiens_hsa03018 | 1.37612633 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.37557350 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.34339823 |
| 39 | RNA transport_Homo sapiens_hsa03013 | 1.32491298 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.28064738 |
| 41 | Purine metabolism_Homo sapiens_hsa00230 | 1.24683841 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.23019359 |
| 43 | Insulin secretion_Homo sapiens_hsa04911 | 1.23010917 |
| 44 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.16037478 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.15820150 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 1.11981865 |
| 47 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.11771726 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.09384169 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.09251847 |
| 50 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.08989117 |
| 51 | Phagosome_Homo sapiens_hsa04145 | 1.08185087 |
| 52 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.06594648 |
| 53 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.04984221 |
| 54 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.02576270 |
| 55 | Asthma_Homo sapiens_hsa05310 | 1.01217720 |
| 56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.98014881 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95181647 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.94525801 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.93877594 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.91510193 |
| 61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.90530255 |
| 62 | Cell cycle_Homo sapiens_hsa04110 | 0.90049241 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89909728 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89874874 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84432563 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84286070 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83882563 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83269086 |
| 69 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.82193620 |
| 70 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81170071 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.80942282 |
| 72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80908833 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80100910 |
| 74 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.79293701 |
| 75 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.77508077 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76867540 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.76856266 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.76503981 |
| 79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76498721 |
| 80 | Nicotine addiction_Homo sapiens_hsa05033 | 0.75282504 |
| 81 | Measles_Homo sapiens_hsa05162 | 0.75062311 |
| 82 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73590845 |
| 83 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.73558815 |
| 84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.73297360 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72334503 |
| 86 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71934272 |
| 87 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.70670814 |
| 88 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68402363 |
| 89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68169416 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65881910 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65598399 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64793587 |
| 93 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.64355704 |
| 94 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.61343163 |
| 95 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.60578353 |
| 96 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.60447974 |
| 97 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.59301283 |
| 98 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.58641482 |
| 99 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57496186 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56915344 |
| 101 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.56665032 |
| 102 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55728950 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55710420 |
| 104 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55668720 |
| 105 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54787869 |
| 106 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51440554 |
| 107 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48306225 |
| 108 | Pertussis_Homo sapiens_hsa05133 | 0.47248912 |
| 109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46279914 |
| 110 | Leishmaniasis_Homo sapiens_hsa05140 | 0.44914474 |
| 111 | Tuberculosis_Homo sapiens_hsa05152 | 0.43951123 |
| 112 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.43404671 |
| 113 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43224374 |
| 114 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42071259 |
| 115 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.41796426 |
| 116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41657581 |
| 117 | Influenza A_Homo sapiens_hsa05164 | 0.41250123 |
| 118 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41057156 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40550427 |
| 120 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40421499 |
| 121 | Shigellosis_Homo sapiens_hsa05131 | 0.40328424 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39721708 |
| 123 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.38865171 |
| 124 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.38778622 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37428737 |
| 126 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.37156573 |
| 127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.36092681 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34902278 |
| 129 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.33814364 |
| 130 | Phototransduction_Homo sapiens_hsa04744 | 0.33238991 |
| 131 | Carbon metabolism_Homo sapiens_hsa01200 | 0.32937348 |
| 132 | Alcoholism_Homo sapiens_hsa05034 | 0.32572629 |
| 133 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.31897771 |
| 134 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.30997494 |
| 135 | Malaria_Homo sapiens_hsa05144 | 0.30921494 |
| 136 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.30578256 |
| 137 | Salmonella infection_Homo sapiens_hsa05132 | 0.28035930 |
| 138 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28020837 |
| 139 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.27596559 |
| 140 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26906752 |
| 141 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26641114 |
| 142 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.26570944 |
| 143 | Taste transduction_Homo sapiens_hsa04742 | 0.25681372 |
| 144 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.25092937 |
| 145 | Lysosome_Homo sapiens_hsa04142 | 0.25075371 |
| 146 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23936983 |
| 147 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.21273848 |
| 148 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.20790406 |
| 149 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.20500527 |
| 150 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.20349245 |
| 151 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.20025233 |
| 152 | Apoptosis_Homo sapiens_hsa04210 | 0.19438639 |

